BCM
Bayesian Capital Management’s Altimmune ALT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.3K | Buy |
+14,300
| New | +$55.3K | 0.01% | 504 |
|
|
2025
Q1 | – | Sell |
-14,700
| Closed | -$106K | – | 589 |
|
|
2024
Q4 | $106K | Buy |
+14,700
| New | +$106K | 0.01% | 610 |
|
|
2023
Q3 | – | Sell |
-30,175
| Closed | -$107K | – | 682 |
|
|
2023
Q2 | $107K | Buy |
30,175
+1,500
| +5% | +$5.3K | 0.01% | 687 |
|
|
2023
Q1 | $121K | Buy |
+28,675
| New | +$121K | 0.02% | 668 |
|
|
2022
Q4 | – | Sell |
-25,409
| Closed | -$324K | – | 759 |
|
|
2022
Q3 | $324K | Buy |
+25,409
| New | +$324K | 0.07% | 394 |
|
|
2022
Q2 | – | Sell |
-16,800
| Closed | -$102K | – | 765 |
|
|
2022
Q1 | $102K | Buy |
+16,800
| New | +$102K | 0.02% | 696 |
|